Latest News

Global stock markets are currently navigating a turbulent and unpredictable landscape, characterized by pervasive volatility, escalating tariff concerns, a mosaic of mixed economic data, and persistent geopolitical risks. This confluence of factors has fostered a palpable sense of caution across major financial hubs, from the bustling trading floors of Wall

The Indian equity market is currently navigating a turbulent period, with benchmark indices Nifty and Sensex experiencing notable declines. This downturn is not isolated to the large-cap segment; broader markets, including the Nifty Midcap 100 and Nifty Smallcap 100, are witnessing even sharper corrections, signaling a widespread sentiment of caution

The US stock market is currently experiencing a period of heightened volatility, with major indices showing mixed signals as investors grapple with economic uncertainties, evolving corporate earnings, and the lingering impact of trade policies. While the broader market has demonstrated resilience in recent months, certain key sectors, notably Technology, Utilities,

The global financial landscape is currently navigating a fascinating divergence in monetary policy, with two of the world's most influential central banks charting distinctly different courses. The Reserve Bank of India (RBI) recently opted to maintain its key repo rate, signaling a cautious yet stable approach amidst evolving economic conditions.

Wall Street is enduring a historically challenging August, with major U.S. indices experiencing significant declines and heightened volatility. This downturn is characterized by a confluence of factors, including persistent investor caution, uncertainty surrounding central bank policies, and escalating geopolitical risks. The immediate implications for investors are a heightened need

Cleveland-Cliffs makes steel the old-fashioned way, which can be great at times but terrible at other times.

Shares of dating app company Match (NASDAQ:MTCH) jumped 10.1% in the afternoon session after the company reported second-quarter results that indicated early signs of a successful turnaround for its key Tinder dating app. The company’s revenue of $864 million remained flat compared to the previous year but surpassed guidance. More impressively, earnings per share crushed analyst expectations. The positive results stemmed from initial improvements in Tinder's user metrics and continued strong operational momentum at the Hinge app. Following the report, Wall Street sentiment improved. JPMorgan lifted its price target to $33, and Goldman Sachs boosted its target to $42. Both firms pointed to the promising product initiatives designed to enhance the Tinder app as a key reason for their optimism.

Shares of electronic components distributor Avnet (NASDAQGS:AVT) fell 8.1% in the afternoon session after the company reported its fourth-quarter financial results and issued a weak forecast for the upcoming quarter. Although the company's quarterly revenue and adjusted earnings surpassed analyst expectations, investors concentrated on the significant year-over-year decline in full-year sales and profits. Avnet's profitability also faltered as operating margins contracted for both the fourth quarter and the entire fiscal year. Capping the report, the company's earnings guidance for the next quarter fell below consensus estimates, suggesting to investors that challenges remained.

Shares of digital vehicle marketplace OPENLANE (NYSE:KAR) jumped 9.6% in the afternoon session after the company reported strong second-quarter financial results that beat analyst expectations and raised its full-year guidance. The used and salvaged vehicle auctioneer reported adjusted earnings of 33 cents per share, which sailed past Wall Street estimates of 24 cents. Revenue for the quarter also landed at $481.7 million, beating expectations of $449 million. Company executives credited the strong performance to their digital-first strategy, which led to a 24% increase in auction fee revenue and a 21% jump in dealer volume. Following the robust quarter, OPENLANE raised its full-year earnings guidance to a range of $1.12 to $1.17 per share.

Shares of upscale restaurant company The One Group Hospitality (NASDAQ:STKS) fell 11.1% in the afternoon session after the company reported disappointing second-quarter 2025 financial results that missed analyst expectations on both revenue and earnings. The upscale restaurant operator posted earnings per share of $0.05, which fell significantly short of the $0.09 consensus forecast. While total revenue grew 20.2% year-over-year to $207.4 million, it still missed estimates. A key point of concern for investors was a 4.1% decline in same-store sales, a metric that tracks performance at existing locations. The company’s net loss also widened to $10.1 million from $7.3 million in the prior year, and it issued a weak revenue forecast for the next quarter, signaling potential challenges ahead.

Shares of online study and academic help platform Chegg (NYSE:CHGG) fell 13.2% in the afternoon session after the company reported dismal second-quarter results that revealed a sharp decline in subscribers and a weak forecast for future revenue. The education technology company reported a steep 40% year-over-year drop in its subscriber numbers, which fell to 2.6 million. This significant decline in users overshadowed the fact that Chegg's revenue and earnings per share actually beat Wall Street's estimates for the quarter. Total revenue decreased by 36% from the previous year, and the company posted a net loss of $35.7 million. Management pointed to lower traffic from Google's AI Overviews as a reason for the slowdown. Looking ahead, the company's third-quarter revenue forecast of $75 million to $77 million also fell short of analyst expectations, signaling continued challenges.

Shares of newspaper and digital media company The New York Times (NYSE:NYT) jumped 15.2% in the afternoon session after the company reported strong second-quarter financial results that surpassed Wall Street expectations and provided an optimistic forecast for future growth. The media company posted revenue of $685.9 million, a nearly 10% jump from the previous year. Adjusted earnings reached $0.58 per share, which beat analysts' projections. This performance stemmed from solid growth in its digital business, where it added approximately 230,000 new digital-only subscribers. Looking ahead, the publisher also forecasted third-quarter subscription revenue growth above market estimates. Management credited this positive outlook to the strength of its bundled offerings, which combined its core news with popular products like The Athletic and Wordle.

Shares of content discovery platform Taboola (NASDAQ:TBLA) jumped 3.9% in the afternoon session after the company reported strong second-quarter financial results that beat expectations and raised its full-year guidance. The content discovery platform announced its revenue grew 8.7% from the previous year to $465.5 million. Its gross profit and adjusted earnings also saw double-digit percentage increases. Buoyed by these results, Taboola lifted its financial forecast for the full year. The company also actively repurchased nearly 12% of its shares in the first half of 2025 and pointed to positive early results from its new "Realize" advertising platform as a driver of growth. This strong performance prompted analysts at B.Riley to upgrade the stock to a 'Buy' rating.

Shares of home services online marketplace ANGI (NASDAQ: ANGI) jumped 16.3% in the afternoon session after the company reported second-quarter results that surpassed Wall Street's revenue expectations. Despite a year-over-year sales decline of 11.7%, the company's strategic pivot towards higher-quality transactions captured investor attention. This new focus, while shedding over $400 million in revenue, resulted in improved operational efficiencies. The shift positively impacted important financial health indicators like EBITDA and free cash flow, which bolstered investor confidence in the company's long-term strategy.

Shares of dialysis provider DaVita Inc. (NYSE:DVA) fell 8.5% in the afternoon session after the company reported a decline in patient treatment volumes and lowered its full-year forecast for the key metric following its second-quarter earnings release. Although the kidney care provider posted second-quarter earnings that beat analyst estimates, investors focused on operational challenges. The company revealed U.S. patient treatment volumes dropped 1.1% year-over-year, a figure below its own projections. This weakness prompted management to lower its full-year forecast for treatment volume. Adding to the concerns, a recent cybersecurity incident cost the company $13 million and negatively affected revenue per treatment. In response to the report, Deutsche Bank also lowered its price target on the stock to $137 from $165, which further fueled the decline.

Shares of slot machine and terminal operator Accel Entertainment (NYSE:ACEL) fell 17.3% in the afternoon session after the company reported second-quarter results that showed a significant drop in profit and missed Wall Street's expectations. While the company posted record quarterly revenue of $335.9 million, an 8.6% increase from the prior year, its net income plummeted. Profits fell by over 50% to $7.3 million. This resulted in earnings per share of $0.08, which was less than half of the $0.17 reported in the same quarter last year and well below analysts' forecasts. The company attributed the sharp decline in net income primarily to a loss related to the changing value of contingent earnout shares, a form of common stock, which contrasted with a gain from the same item in the previous year.

Shares of life sciences company Bio-Techne (NASDAQ:TECH) fell 6.5% in the afternoon session after the company reported its fourth-quarter fiscal 2025 results, which included a significant net loss driven by a large impairment charge. The company posted a net loss of $17.68 million, a sharp reversal from the $40.59 million in net income recorded a year ago. This loss resulted from an $83.1 million impairment charge linked to the divestiture of its Exosome Diagnostics business. An impairment charge is an accounting entry used when an asset's value falls below its recorded worth. Furthermore, the company's gross margin tightened and it recorded an operating loss of $23.9 million, compared to an operating profit of $45.8 million in the prior year. The Diagnostics and Spatial Biology division also experienced a 1% decrease in sales.

Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) fell 4.4% in the afternoon session after the company reported mixed second-quarter financial results, where a massive net loss overshadowed a revenue beat and raised guidance. The contract research organization posted revenues of $710.3 million, which exceeded analysts' expectations. However, investors focused on a staggering GAAP net loss of $374.9 million for the quarter. This loss resulted primarily from a non-cash goodwill impairment charge of $309.1 million. A goodwill impairment is an accounting adjustment made when the value of a company's assets declined. Fortrea attributed this charge to its own falling share price and market-driven interest rate increases. Further concerns arose from a weak book-to-bill ratio of 0.79x, which indicated the company secured less new business than it billed during the period.

Shares of medical device company LeMaitre Vascular (NASDAQ:LMAT) jumped 9.5% in the afternoon session after the company reported better-than-expected second-quarter financial results and raised its full-year outlook. The medical device maker reported second-quarter earnings per share of $0.60 on revenue of $64.2 million, which beat Wall Street's expectations. The company's sales jumped 15% from the previous year, pushed by higher prices and a 7% increase in the number of products sold. Strong international sales for its Artegraft product also contributed to the growth. Looking ahead, LeMaitre lifted its full-year 2025 revenue forecast to $251 million and increased its earnings guidance, signaling management's confidence in continued strong performance.

Shares of specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ:SUPN) jumped 14.4% in the afternoon session after the company posted strong second-quarter earnings that beat expectations and raised its full-year revenue forecast. The pharmaceutical company reported revenues of $165.5 million, which surpassed analysts' projections, while its earnings per share of $0.40 also beat consensus estimates. Investors reacted positively to the growth in key products, as net sales for Qelbree and GOCOVRI increased by 31% and 16% respectively, compared to the prior year. Bolstering investor confidence, Supernus lifted its full-year revenue guidance, pointing to a strong first-half performance. The company also completed the acquisition of Sage Therapeutics and launched a new device for Parkinson's disease, which further supported the positive sentiment.

Shares of home automation and security solutions provider Resideo Technologies (NYSE:REZI) jumped 7.5% in the afternoon session after the company reported record second-quarter financial results that beat analyst expectations and raised its full-year guidance. The company posted record revenue of $1.94 billion, a 22% increase from the previous year, and adjusted earnings per share of $0.66. These figures surpassed Wall Street's forecasts. While Resideo recorded a net loss of $825 million, this resulted from a one-time expense to end an agreement with Honeywell. Investors appeared to focus on the strong operational performance, as both its Products and Solutions and ADI segments achieved organic revenue growth. In a sign of confidence, the company also lifted its full-year 2025 financial outlook and announced plans to spin off its ADI business segment.

Shares of welding and cutting equipment manufacturer ESAB (NYSE:ESAB) fell 16.7% in the afternoon session after the company reported a decline in its second-quarter profit and underlying sales. The company's net income dropped to $66.88 million from $82.91 million a year earlier, and earnings per share also decreased. While acquisitions helped lift total sales by 1%, core organic sales, a key measure of underlying performance, actually slipped by 1%. A significant weak spot appeared in the Americas segment, where sales fell 9% from the prior year, a downturn the company attributed to tariff impacts. Despite these challenges, ESAB raised its full-year guidance, but investors appeared to concentrate on the erosion in profit and the sales weakness in a key region.